Kumquat Biosciences
PrivateLast Round
Strategic
Jul 29, 2021
Est. Valuation
$304.89M
Total Funding Raised
$231.9M
Company Overview
Kumquat Biosciences is a biotechnology company that develops small-molecule immunotherapies and oncology medicines to treat cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kumquat Biosciences Comparables
Compare Kumquat Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Quanta Therapeutics | 87% | |
| Tyligand Bioscience | 86% | |
| BridgeBio Pharma, Inc. | 82% | |
Kumquat Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jul 29, 2021 | ||||
| Series A Extension | Feb 5, 2021 | ||||
| Series A | Sep 8, 2019 |
Key People
Founding team and executive leadership
Kumquat Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EcoR1 Capital | Series A, Strategic, Series A Extension |
| Roche Venture Fund | Series A, Strategic, Series A Extension |
| OrbiMed | Series A, Strategic, Series A Extension |
| Roche Venture Fund | Series A, Series A Extension |
| Lilly Asia Ventures | Series A, Strategic, Series A Extension |
| Lilly Asia Ventures | Series A, Series A Extension |
| HongShan | Series A, Strategic, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 13, 2025
Developing KRAS G12D candidate in partnership with Bayer.
- Aug 13, 2025
Partnered with Bayer to co-develop an oncology candidate.
Kumquat Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Kumquat Biosciences's valuation, stock price, and market status.